Market Analysis and Insights: Global Celiac Drugs Market
The global Celiac Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Celiac Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Celiac Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Celiac Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Celiac Drugs market.
Global Celiac Drugs Scope and Market Size
The research report includes specific segments by region (country),
by company,
by Type and
by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2018 to 2032. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
- First Line Of Treatment
- Second Line Of Treatment
Segment by Application
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- U.A.E
By Company
- ADMA Biologics
- Amgen
- Anthera Pharmaceuticals
- Bayer
- Biogen
- BioLineRx
- Biotest
- Bristol-Myers Squibb
- Celgene
- Celimmune
- F Hoffmann-La Roche
- ImmunogenX
- Immunomedics
- ImmusanT
- Innovate Biopharmaceuticals
- Johnson & Johnson
- Kedrion Biopharma
- LFB Group
- Merck
- Novartis
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Celiac Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Celiac Drugs, with price, sales, revenue, and global market share of Celiac Drugs from 2019 to 2022.
Chapter 3, the Celiac Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Celiac Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Celiac Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Celiac Drugs.
Chapter 13, 14, and 15, to describe Celiac Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Celiac Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
TABLE OF CONTENTS
1 Celiac Drugs Market Overview
1.1 Product Overview and Scope of Celiac Drugs
1.2 Celiac Drugs Segment by Type
1.2.1 Global Celiac Drugs Sales Growth Rate Comparison by Type (2023-2032)
1.2.2 First Line Of Treatment
1.2.3 Second Line Of Treatment
1.3 Celiac Drugs Segment by Application
1.3.1 Global Celiac Drugs Sales Comparison by Application: (2023-2032)
1.3.2 Men
1.3.3 Women
1.3.4 Children
1.4 Global Celiac Drugs Market Size Estimates and Forecasts
1.4.1 Global Celiac Drugs Revenue 2018-2032
1.4.2 Global Celiac Drugs Sales 2018-2032
1.4.3 Celiac Drugs Market Size by Region: 2018 Versus 2022 Versus 2032
2 Celiac Drugs Market Competition by Manufacturers
2.1 Global Celiac Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Celiac Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Celiac Drugs Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Celiac Drugs Manufacturing Sites, Area Served, Product Type
2.5 Celiac Drugs Market Competitive Situation and Trends
2.5.1 Celiac Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Celiac Drugs Players Market Share by Revenue
2.5.3 Global Celiac Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Celiac Drugs Retrospective Market Scenario by Region
3.1 Global Celiac Drugs Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Celiac Drugs Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Celiac Drugs Market Facts & Figures by Country
3.3.1 North America Celiac Drugs Sales by Country
3.3.2 North America Celiac Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Celiac Drugs Market Facts & Figures by Country
3.4.1 Europe Celiac Drugs Sales by Country
3.4.2 Europe Celiac Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Celiac Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Celiac Drugs Sales by Region
3.5.2 Asia Pacific Celiac Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Celiac Drugs Market Facts & Figures by Country
3.6.1 Latin America Celiac Drugs Sales by Country
3.6.2 Latin America Celiac Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Celiac Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Celiac Drugs Sales by Country
3.7.2 Middle East and Africa Celiac Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Celiac Drugs Historic Market Analysis by Type
4.1 Global Celiac Drugs Sales Market Share by Type (2018-2023)
4.2 Global Celiac Drugs Revenue Market Share by Type (2018-2023)
4.3 Global Celiac Drugs Price by Type (2018-2023)
5 Global Celiac Drugs Historic Market Analysis by Application
5.1 Global Celiac Drugs Sales Market Share by Application (2018-2023)
5.2 Global Celiac Drugs Revenue Market Share by Application (2018-2023)
5.3 Global Celiac Drugs Price by Application (2018-2023)
6 Key Companies Profiled
6.1 ADMA Biologics
6.1.1 ADMA Biologics Corporation Information
6.1.2 ADMA Biologics Description and Business Overview
6.1.3 ADMA Biologics Celiac Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 ADMA Biologics Celiac Drugs Product Portfolio
6.1.5 ADMA Biologics Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Celiac Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Amgen Celiac Drugs Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Anthera Pharmaceuticals
6.3.1 Anthera Pharmaceuticals Corporation Information
6.3.2 Anthera Pharmaceuticals Description and Business Overview
6.3.3 Anthera Pharmaceuticals Celiac Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Anthera Pharmaceuticals Celiac Drugs Product Portfolio
6.3.5 Anthera Pharmaceuticals Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Celiac Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bayer Celiac Drugs Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Biogen
6.5.1 Biogen Corporation Information
6.5.2 Biogen Description and Business Overview
6.5.3 Biogen Celiac Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Biogen Celiac Drugs Product Portfolio
6.5.5 Biogen Recent Developments/Updates
6.6 BioLineRx
6.6.1 BioLineRx Corporation Information
6.6.2 BioLineRx Description and Business Overview
6.6.3 BioLineRx Celiac Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 BioLineRx Celiac Drugs Product Portfolio
6.6.5 BioLineRx Recent Developments/Updates
6.7 Biotest
6.6.1 Biotest Corporation Information
6.6.2 Biotest Description and Business Overview
6.6.3 Biotest Celiac Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biotest Celiac Drugs Product Portfolio
6.7.5 Biotest Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Corporation Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb Celiac Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Bristol-Myers Squibb Celiac Drugs Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
6.9 Celgene
6.9.1 Celgene Corporation Information
6.9.2 Celgene Description and Business Overview
6.9.3 Celgene Celiac Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Celgene Celiac Drugs Product Portfolio
6.9.5 Celgene Recent Developments/Updates
6.10 Celimmune
6.10.1 Celimmune Corporation Information
6.10.2 Celimmune Description and Business Overview
6.10.3 Celimmune Celiac Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Celimmune Celiac Drugs Product Portfolio
6.10.5 Celimmune Recent Developments/Updates
6.11 F Hoffmann-La Roche
6.11.1 F Hoffmann-La Roche Corporation Information
6.11.2 F Hoffmann-La Roche Celiac Drugs Description and Business Overview
6.11.3 F Hoffmann-La Roche Celiac Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 F Hoffmann-La Roche Celiac Drugs Product Portfolio
6.11.5 F Hoffmann-La Roche Recent Developments/Updates
6.12 ImmunogenX
6.12.1 ImmunogenX Corporation Information
6.12.2 ImmunogenX Celiac Drugs Description and Business Overview
6.12.3 ImmunogenX Celiac Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 ImmunogenX Celiac Drugs Product Portfolio
6.12.5 ImmunogenX Recent Developments/Updates
6.13 Immunomedics
6.13.1 Immunomedics Corporation Information
6.13.2 Immunomedics Celiac Drugs Description and Business Overview
6.13.3 Immunomedics Celiac Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Immunomedics Celiac Drugs Product Portfolio
6.13.5 Immunomedics Recent Developments/Updates
6.14 ImmusanT
6.14.1 ImmusanT Corporation Information
6.14.2 ImmusanT Celiac Drugs Description and Business Overview
6.14.3 ImmusanT Celiac Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 ImmusanT Celiac Drugs Product Portfolio
6.14.5 ImmusanT Recent Developments/Updates
6.15 Innovate Biopharmaceuticals
6.15.1 Innovate Biopharmaceuticals Corporation Information
6.15.2 Innovate Biopharmaceuticals Celiac Drugs Description and Business Overview
6.15.3 Innovate Biopharmaceuticals Celiac Drugs Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Innovate Biopharmaceuticals Celiac Drugs Product Portfolio
6.15.5 Innovate Biopharmaceuticals Recent Developments/Updates
6.16 Johnson & Johnson
6.16.1 Johnson & Johnson Corporation Information
6.16.2 Johnson & Johnson Celiac Drugs Description and Business Overview
6.16.3 Johnson & Johnson Celiac Drugs Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Johnson & Johnson Celiac Drugs Product Portfolio
6.16.5 Johnson & Johnson Recent Developments/Updates
6.17 Kedrion Biopharma
6.17.1 Kedrion Biopharma Corporation Information
6.17.2 Kedrion Biopharma Celiac Drugs Description and Business Overview
6.17.3 Kedrion Biopharma Celiac Drugs Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Kedrion Biopharma Celiac Drugs Product Portfolio
6.17.5 Kedrion Biopharma Recent Developments/Updates
6.18 LFB Group
6.18.1 LFB Group Corporation Information
6.18.2 LFB Group Celiac Drugs Description and Business Overview
6.18.3 LFB Group Celiac Drugs Sales, Revenue and Gross Margin (2018-2023)
6.18.4 LFB Group Celiac Drugs Product Portfolio
6.18.5 LFB Group Recent Developments/Updates
6.19 Merck
6.19.1 Merck Corporation Information
6.19.2 Merck Celiac Drugs Description and Business Overview
6.19.3 Merck Celiac Drugs Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Merck Celiac Drugs Product Portfolio
6.19.5 Merck Recent Developments/Updates
6.20 Novartis
6.20.1 Novartis Corporation Information
6.20.2 Novartis Celiac Drugs Description and Business Overview
6.20.3 Novartis Celiac Drugs Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Novartis Celiac Drugs Product Portfolio
6.20.5 Novartis Recent Developments/Updates
7 Celiac Drugs Manufacturing Cost Analysis
7.1 Celiac Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Celiac Drugs
7.4 Celiac Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Celiac Drugs Distributors List
8.3 Celiac Drugs Customers
9 Celiac Drugs Market Dynamics
9.1 Celiac Drugs Industry Trends
9.2 Celiac Drugs Market Drivers
9.3 Celiac Drugs Market Challenges
9.4 Celiac Drugs Market Restraints
10 Global Market Forecast
10.1 Celiac Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Celiac Drugs by Type (2023-2032)
10.1.2 Global Forecasted Revenue of Celiac Drugs by Type (2023-2032)
10.2 Celiac Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Celiac Drugs by Application (2023-2032)
10.2.2 Global Forecasted Revenue of Celiac Drugs by Application (2023-2032)
10.3 Celiac Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Celiac Drugs by Region (2023-2032)
10.3.2 Global Forecasted Revenue of Celiac Drugs by Region (2023-2032)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Celiac Drugs Sales Growth Rate Comparison by Type (2023-2032) & (K Units) & (US$ Million)
Table 2. Global Celiac Drugs Sales Growth Rate Comparison by Application (2023-2032) & (K Units) & (US$ Million)
Table 3. Global Celiac Drugs Market Size by Region (US$ Million) (2018 VS 2022 VS 2032)
Table 4. Global Celiac Drugs Market Competitive Situation by Manufacturers in 2022
Table 5. Global Celiac Drugs Sales (K Units) of Key Manufacturers (2018-2023)
Table 6. Global Celiac Drugs Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Celiac Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 8. Global Celiac Drugs Revenue Share by Manufacturers (2018-2023)
Table 9. Global Market Celiac Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 10. Manufacturers Celiac Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Celiac Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Celiac Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Celiac Drugs as of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Celiac Drugs Sales by Region (2018-2023) & (K Units)
Table 16. Global Celiac Drugs Sales Market Share by Region (2018-2023)
Table 17. Global Celiac Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 18. Global Celiac Drugs Revenue Market Share by Region (2018-2023)
Table 19. North America Celiac Drugs Sales by Country (2018-2023) & (K Units)
Table 20. North America Celiac Drugs Sales Market Share by Country (2018-2023)
Table 21. North America Celiac Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 22. North America Celiac Drugs Revenue Market Share by Country (2018-2023)
Table 23. Europe Celiac Drugs Sales by Country (2018-2023) & (K Units)
Table 24. Europe Celiac Drugs Sales Market Share by Country (2018-2023)
Table 25. Europe Celiac Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 26. Europe Celiac Drugs Revenue Market Share by Country (2018-2023)
Table 27. Asia Pacific Celiac Drugs Sales by Region (2018-2023) & (K Units)
Table 28. Asia Pacific Celiac Drugs Sales Market Share by Region (2018-2023)
Table 29. Asia Pacific Celiac Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 30. Asia Pacific Celiac Drugs Revenue Market Share by Region (2018-2023)
Table 31. Latin America Celiac Drugs Sales by Country (2018-2023) & (K Units)
Table 32. Latin America Celiac Drugs Sales Market Share by Country (2018-2023)
Table 33. Latin America Celiac Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Latin America Celiac Drugs Revenue Market Share by Country (2018-2023)
Table 35. Middle East and Africa Celiac Drugs Sales by Country (2018-2023) & (K Units)
Table 36. Middle East and Africa Celiac Drugs Sales Market Share by Country (2018-2023)
Table 37. Middle East and Africa Celiac Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 38. Middle East and Africa Celiac Drugs Revenue Market Share by Country (2018-2023)
Table 39. Global Celiac Drugs Sales by Type (2018-2023) & (K Units)
Table 40. Global Celiac Drugs Sales Market Share by Type (2018-2023)
Table 41. Global Celiac Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 42. Global Celiac Drugs Revenue Share by Type (2018-2023)
Table 43. Global Celiac Drugs Price by Type (2018-2023) & (USD/Unit)
Table 44. Global Celiac Drugs Sales (K Units) by Application (2018-2023)
Table 45. Global Celiac Drugs Sales Market Share by Application (2018-2023)
Table 46. Global Celiac Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Celiac Drugs Revenue Share by Application (2018-2023)
Table 48. Global Celiac Drugs Price by Application (2018-2023) & (USD/Unit)
Table 49. ADMA Biologics Corporation Information
Table 50. ADMA Biologics Description and Business Overview
Table 51. ADMA Biologics Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 52. ADMA Biologics Celiac Drugs Product
Table 53. ADMA Biologics Recent Developments/Updates
Table 54. Amgen Corporation Information
Table 55. Amgen Description and Business Overview
Table 56. Amgen Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 57. Amgen Celiac Drugs Product
Table 58. Amgen Recent Developments/Updates
Table 59. Anthera Pharmaceuticals Corporation Information
Table 60. Anthera Pharmaceuticals Description and Business Overview
Table 61. Anthera Pharmaceuticals Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 62. Anthera Pharmaceuticals Celiac Drugs Product
Table 63. Anthera Pharmaceuticals Recent Developments/Updates
Table 64. Bayer Corporation Information
Table 65. Bayer Description and Business Overview
Table 66. Bayer Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 67. Bayer Celiac Drugs Product
Table 68. Bayer Recent Developments/Updates
Table 69. Biogen Corporation Information
Table 70. Biogen Description and Business Overview
Table 71. Biogen Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 72. Biogen Celiac Drugs Product
Table 73. Biogen Recent Developments/Updates
Table 74. BioLineRx Corporation Information
Table 75. BioLineRx Description and Business Overview
Table 76. BioLineRx Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. BioLineRx Celiac Drugs Product
Table 78. BioLineRx Recent Developments/Updates
Table 79. Biotest Corporation Information
Table 80. Biotest Description and Business Overview
Table 81. Biotest Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Biotest Celiac Drugs Product
Table 83. Biotest Recent Developments/Updates
Table 84. Bristol-Myers Squibb Corporation Information
Table 85. Bristol-Myers Squibb Description and Business Overview
Table 86. Bristol-Myers Squibb Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Bristol-Myers Squibb Celiac Drugs Product
Table 88. Bristol-Myers Squibb Recent Developments/Updates
Table 89. Celgene Corporation Information
Table 90. Celgene Description and Business Overview
Table 91. Celgene Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Celgene Celiac Drugs Product
Table 93. Celgene Recent Developments/Updates
Table 94. Celimmune Corporation Information
Table 95. Celimmune Description and Business Overview
Table 96. Celimmune Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Celimmune Celiac Drugs Product
Table 98. Celimmune Recent Developments/Updates
Table 99. F Hoffmann-La Roche Corporation Information
Table 100. F Hoffmann-La Roche Description and Business Overview
Table 101. F Hoffmann-La Roche Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. F Hoffmann-La Roche Celiac Drugs Product
Table 103. F Hoffmann-La Roche Recent Developments/Updates
Table 104. ImmunogenX Corporation Information
Table 105. ImmunogenX Description and Business Overview
Table 106. ImmunogenX Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. ImmunogenX Celiac Drugs Product
Table 108. ImmunogenX Recent Developments/Updates
Table 109. Immunomedics Corporation Information
Table 110. Immunomedics Description and Business Overview
Table 111. Immunomedics Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Immunomedics Celiac Drugs Product
Table 113. Immunomedics Recent Developments/Updates
Table 114. ImmusanT Corporation Information
Table 115. ImmusanT Description and Business Overview
Table 116. ImmusanT Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. ImmusanT Celiac Drugs Product
Table 118. ImmusanT Recent Developments/Updates
Table 119. Innovate Biopharmaceuticals Corporation Information
Table 120. Innovate Biopharmaceuticals Description and Business Overview
Table 121. Innovate Biopharmaceuticals Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Innovate Biopharmaceuticals Celiac Drugs Product
Table 123. Innovate Biopharmaceuticals Recent Developments/Updates
Table 124. Johnson & Johnson Corporation Information
Table 125. Johnson & Johnson Description and Business Overview
Table 126. Johnson & Johnson Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Johnson & Johnson Celiac Drugs Product
Table 128. Johnson & Johnson Recent Developments/Updates
Table 129. Kedrion Biopharma Corporation Information
Table 130. Kedrion Biopharma Description and Business Overview
Table 131. Kedrion Biopharma Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. Kedrion Biopharma Celiac Drugs Product
Table 133. Kedrion Biopharma Recent Developments/Updates
Table 134. LFB Group Corporation Information
Table 135. LFB Group Description and Business Overview
Table 136. LFB Group Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 137. LFB Group Celiac Drugs Product
Table 138. LFB Group Recent Developments/Updates
Table 139. Merck Corporation Information
Table 140. Merck Description and Business Overview
Table 141. Merck Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 142. Merck Celiac Drugs Product
Table 143. Merck Recent Developments/Updates
Table 144. Novartis Corporation Information
Table 145. Novartis Description and Business Overview
Table 146. Novartis Celiac Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 147. Novartis Celiac Drugs Product
Table 148. Novartis Recent Developments/Updates
Table 149. Production Base and Market Concentration Rate of Raw Material
Table 150. Key Suppliers of Raw Materials
Table 151. Celiac Drugs Distributors List
Table 152. Celiac Drugs Customers List
Table 153. Celiac Drugs Market Trends
Table 154. Celiac Drugs Market Drivers
Table 155. Celiac Drugs Market Challenges
Table 156. Celiac Drugs Market Restraints
Table 157. Global Celiac Drugs Sales Forecast by Type (2023-2032) & (K Units)
Table 158. Global Celiac Drugs Sales Market Share Forecast by Type (2023-2032)
Table 159. Global Celiac Drugs Revenue Forecast by Type (2023-2032) & (US$ Million)
Table 160. Global Celiac Drugs Revenue Market Share Forecast by Type (2023-2032)
Table 161. Global Celiac Drugs Sales Forecast by Application (2023-2032) & (K Units)
Table 162. Global Celiac Drugs Sales Market Share Forecast by Application (2023-2032)
Table 163. Global Celiac Drugs Revenue Forecast by Application (2023-2032) & (US$ Million)
Table 164. Global Celiac Drugs Revenue Market Share Forecast by Application (2023-2032)
Table 165. Global Celiac Drugs Sales Forecast by Region (2023-2032) & (K Units)
Table 166. Global Celiac Drugs Sales Market Share Forecast by Region (2023-2032)
Table 167. Global Celiac Drugs Revenue Forecast by Region (2023-2032) & (US$ Million)
Table 168. Global Celiac Drugs Revenue Market Share Forecast by Region (2023-2032)
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Celiac Drugs
Figure 2. Global Celiac Drugs Market Share by Type in 2022 & 2032
Figure 3. First Line Of Treatment Product Picture
Figure 4. Second Line Of Treatment Product Picture
Figure 5. Global Celiac Drugs Market Share by Application in 2022 & 2032
Figure 6. Men
Figure 7. Women
Figure 8. Children
Figure 9. Global Celiac Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2032
Figure 10. Global Celiac Drugs Market Size (2018-2032) & (US$ Million)
Figure 11. Global Celiac Drugs Sales (2018-2032) & (K Units)
Figure 12. Celiac Drugs Sales Share by Manufacturers in 2022
Figure 13. Global Celiac Drugs Revenue Share by Manufacturers in 2022
Figure 14. The Global 5 and 10 Largest Celiac Drugs Players: Market Share by Revenue in 2022
Figure 15. Celiac Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 16. Global Celiac Drugs Sales Market Share by Region (2018-2023)
Figure 17. Global Celiac Drugs Sales Market Share by Region in 2022
Figure 18. Global Celiac Drugs Revenue Market Share by Region (2018-2023)
Figure 19. Global Celiac Drugs Revenue Market Share by Region in 2022
Figure 20. U.S. Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 21. Canada Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 22. Germany Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 23. France Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 24. U.K. Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 25. Italy Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 26. Russia Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 27. China Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 28. Japan Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 29. South Korea Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 30. India Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 31. Australia Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 32. Taiwan Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 33. Indonesia Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 34. Thailand Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 35. Malaysia Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 36. Philippines Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 37. Vietnam Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 38. Mexico Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 39. Brazil Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 40. Argentina Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 41. Turkey Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 42. Saudi Arabia Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 43. U.A.E Celiac Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 44. Sales Market Share of Celiac Drugs by Type (2018-2023)
Figure 45. Manufacturing Cost Structure of Celiac Drugs
Figure 46. Manufacturing Process Analysis of Celiac Drugs
Figure 47. Celiac Drugs Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
